Free Trial

Pliant Therapeutics (PLRX) SEC Filings & 10K Form

$12.13
-0.04 (-0.33%)
(As of 05/31/2024 ET)

Recent Pliant Therapeutics SEC Filings

DateFilerForm TypeView
05/14/2024
6:43 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
3:27 PM
Pliant Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
5:02 AM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:45 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
3:20 PM
Pliant Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2024
7:55 PM
Blue Owl Capital Holdings LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
02/14/2024
4:10 PM
First Light Asset Management, LLC (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
02/14/2024
7:52 AM
Deep Track Capital, LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:28 AM
FMR LLC (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G/A
02/08/2024
11:29 AM
Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
02/05/2024
6:31 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
3:59 PM
BlackRock Inc. (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
01/24/2024
3:56 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:18 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:19 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:19 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:19 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:11 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
6:34 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
7:50 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
3:11 PM
Hull Hans (Reporting)
Pliant Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/21/2023
3:40 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
7:23 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
7:26 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
7:29 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
7:31 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
7:20 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
6:26 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
6:17 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
6:19 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
6:22 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
6:14 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
5:14 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
5:19 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
4:11 PM
CROWELL GAYLE A (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
4:14 PM
Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
4:16 PM
Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
4:19 PM
Knobil Katharine (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
4:22 PM
MCCOURT Thomas A (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
4:24 PM
Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
4:26 PM
Pliant Therapeutics (Issuer)
Shah Smital (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump conviction scandal exposed (Ad)

In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election…

To get all the details, go here now.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PLRX) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners